TY  - GEN
AU  - Luetkemeyer,Anne F
AU  - Rosenkranz,Susan L
AU  - Lu,Darlene
AU  - Grinsztejn,Beatriz
AU  - Sanchez,Jorge
AU  - Ssemmanda,Michael
AU  - Sanne,Ian
AU  - McIlleron,Helen
AU  - Havlir,Diane V
AU  - Haas,David W
TI  - Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study
SN  - 1537-6591
PY  - 2016///0222
KW  - Alkynes
KW  - Antitubercular Agents
KW  - blood
KW  - Arylamine N-Acetyltransferase
KW  - genetics
KW  - Benzoxazines
KW  - Cyclopropanes
KW  - Cytochrome P-450 CYP2B6
KW  - Female
KW  - Genotype
KW  - HIV Infections
KW  - complications
KW  - Humans
KW  - Male
KW  - Peru
KW  - Pharmacogenetics
KW  - Rifampin
KW  - therapeutic use
KW  - South Africa
KW  - Tuberculosis
KW  - Uganda
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/cid/civ155
ER  -